RLMD · Relmada Therapeutics, Inc.
$4.80
+0.05 (+1.05%)
At close · Aug 14
Market Cap
$512.02M
Shares
106.67M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
4,000,000 shares
as of 2014-03-10
· not restated in filings since 2014-09-09
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 | $6,457,890 Δ | 10-Q, filed 2026-08-06 |
| 2026-03-31 | $3,360,000 | 10-Q, filed 2026-05-12 |
Key facts
CIK
1553643
CUSIP
75955J402
13F (30d)
126 filings
124 filers
Visit website
Investor relations